Contract manufacturer specializing in biopharmaceutical production, offering development and manufacturing services for therapies and cell cultures.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
BioInno is a Contract Development and Manufacturing Organization (CDMO) that specializes in the production of biopharmaceuticals. It offers a wide range of services, including the development of antibodies, cell therapies, gene therapies, and custom cell culture media. The company supports its clients with comprehensive manufacturing solutions, from product development to commercial supply.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
BioInno Management Team
BioInno Valuations & Financials
View real-time NPM data on BioInno stock including daily BioInno stock price estimates, valuation history, and historical share price information. Access BioInno financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track BioInno pricing across six independent market signals. Looking for private company due diligence data sources on BioInno? Get in touch to learn more.
Similar Companies
like BioInno
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
SingleFile Technologies
Enterprise Software
Automates entity compliance tasks and simplifies regulatory filings into a unified, smart workflow.
Substack
Media & Entertainment
Lets writers connect with their audience on their own terms and earn money doing it.
Starbird
Consumer
Operates automated restaurants that use robotic systems to prepare food and manage kitchen operations.
Color
Healthcare & Life Sciences
Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.
Consensus
AI & Machine Learning
Uses AI to search and synthesize scientific research answers grounded in peer-reviewed literature for clearer evidence-based insights.
Glimpse
AI & Machine Learning
Glimpse provides an AI-powered, fully managed service that automates deduction management for consumer-packaged goods brands.
FAQ
We have answers
BioInno stock does not trade on public stock exchanges. BioInno stock is considered a private security and you need to be an accredited investor to trade shares. To invest in BioInno stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
BioInno Stock does not trade on public stock exchanges. In order to sell BioInno shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
BioInno does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view BioInno share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for BioInno stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell BioInno stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in BioInno stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
BioInno is a private company and has not had an IPO. There is currently no BioInno IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to BioInno IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
